Efficacy-Based Budget Impact Analysis of Secukinumab Vs Adalimumab in the Treatment of Ankylosing Spondylitis in Finland

Oct 1, 2017, 00:00
10.1016/j.jval.2017.08.737
https://www.valueinhealthjournal.com/article/S1098-3015(17)31071-9/fulltext
Title : Efficacy-Based Budget Impact Analysis of Secukinumab Vs Adalimumab in the Treatment of Ankylosing Spondylitis in Finland
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(17)31071-9&doi=10.1016/j.jval.2017.08.737
First page : A528
Section Title : Disease-Specific Studies
Open access? : No
Section Order : 701
Categories :
Tags :
Regions :
ViH Article Tags :